Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
The mitochondrion is an important intracellular organelle for drug targeting due to its key roles and functions in cellular proliferation and death. In the last few decades, several studies have revealed mitochondrial functions, attracting the focus of many researchers to work in this field over nuc...
Main Authors: | Gantumur Battogtokh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00922/full |
Similar Items
-
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
by: Ludmila A. Zinovkina, et al.
Published: (2020-03-01) -
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
by: Zhang S, et al.
Published: (2018-07-01) -
Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
by: Daniel Chavarria, et al.
Published: (2021-02-01) -
Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents
by: Andrea Mattarei, et al.
Published: (2018-04-01) -
Investigating the effects of structural modification of alkyl triphenylphosphonium compounds on mitochondrial uncoupling and accumulation
by: Kulkarni, Chaitanya Aniruddha
Published: (2017)